Cellogen Therapeutics Raises ₹20 Crore to Advance CAR-T Cancer Therapy and Gene Research
Delhi-based Cellogen Therapeutics, a biotechnology startup focused on cell and gene therapy, has raised ₹20 crore (approximately $2 million) in funding from Kotak Alternate Asset Managers. The fresh investment will support the company’s efforts to accelerate development of advanced CAR-T cancer therapies, strengthen gene therapy research programs, and scale manufacturing capabilities. Funding to Support CAR-T … Read more
